Multicentre, Double-Blind, Randomised, Parallel Group, Placebo Controlled, Phase 3 Study of the Efficacy and Safety of Quetiapine Fumarate and Paroxetine as Monotherapy in Adult Patients With Bipolar Depression for 8 Weeks and Quetiapine in Continuation (Abbreviated)

Trial Profile

Multicentre, Double-Blind, Randomised, Parallel Group, Placebo Controlled, Phase 3 Study of the Efficacy and Safety of Quetiapine Fumarate and Paroxetine as Monotherapy in Adult Patients With Bipolar Depression for 8 Weeks and Quetiapine in Continuation (Abbreviated)

Completed
Phase of Trial: Phase III

Latest Information Update: 01 Feb 2014

At a glance

  • Drugs Quetiapine (Primary) ; Paroxetine
  • Indications Bipolar disorders; Bipolar I disorders; Bipolar II disorders
  • Focus Registrational; Therapeutic Use
  • Acronyms EMBOLDEN-II
  • Most Recent Events

    • 26 Feb 2010 Results were published in the Journal of Clinical Psychiatry.
    • 03 Sep 2008 Results were presented at ECNP 2008.
    • 02 Nov 2007 Status change from in progress to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top